CN1301253C - 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途 - Google Patents
五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途 Download PDFInfo
- Publication number
- CN1301253C CN1301253C CNB031500587A CN03150058A CN1301253C CN 1301253 C CN1301253 C CN 1301253C CN B031500587 A CNB031500587 A CN B031500587A CN 03150058 A CN03150058 A CN 03150058A CN 1301253 C CN1301253 C CN 1301253C
- Authority
- CN
- China
- Prior art keywords
- compound
- trans
- general formula
- definition
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
溶剂对照 | S8(10μg/ml) | S8(5μg/ml) | S8(2.5μg/ml) |
21586±1411 | 33±5 | 100±18 | 150±20 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031500587A CN1301253C (zh) | 2003-07-31 | 2003-07-31 | 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031500587A CN1301253C (zh) | 2003-07-31 | 2003-07-31 | 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1580054A CN1580054A (zh) | 2005-02-16 |
CN1301253C true CN1301253C (zh) | 2007-02-21 |
Family
ID=34579776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031500587A Expired - Fee Related CN1301253C (zh) | 2003-07-31 | 2003-07-31 | 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1301253C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1680384A (zh) * | 2004-04-08 | 2005-10-12 | 香港中文大学 | 去甲基斑蟊素铂配合物及其用途 |
WO2006034604A1 (fr) * | 2004-09-28 | 2006-04-06 | Beijing Molecule Science And Technology Co., Ltd | Composes s-heterocycliques a 5 elements et leur utilisation dans la preparation de medicaments pour le traitement ou la prevention de maladies associees a l’obesite |
CN101190904A (zh) * | 2006-11-23 | 2008-06-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 脂肪酸合成酶抑制剂及其制药用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4310517A (en) * | 1976-12-28 | 1982-01-12 | Troponwerke Gmbh & Co., Kg | Tumor-resolving and histolytic medicaments and their use |
US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
CN1278256A (zh) * | 1997-09-05 | 2000-12-27 | 罗赫诊断器材股份有限公司 | 用作抗肿瘤剂的4-氨基-2(5h)-呋喃酮和4-氨基-2(5h)-噻吩酮的脲基和硫脲基衍生物 |
-
2003
- 2003-07-31 CN CNB031500587A patent/CN1301253C/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4310517A (en) * | 1976-12-28 | 1982-01-12 | Troponwerke Gmbh & Co., Kg | Tumor-resolving and histolytic medicaments and their use |
US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
CN1278256A (zh) * | 1997-09-05 | 2000-12-27 | 罗赫诊断器材股份有限公司 | 用作抗肿瘤剂的4-氨基-2(5h)-呋喃酮和4-氨基-2(5h)-噻吩酮的脲基和硫脲基衍生物 |
Also Published As
Publication number | Publication date |
---|---|
CN1580054A (zh) | 2005-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1153569C (zh) | 富马酸衍生物的应用 | |
KR101363308B1 (ko) | 비만을 치료하기 위한 벤조―융합된 헤테로사이클 설파미드유도체의 용도 | |
CN109477993B (zh) | β-羟基丁酸酯和丁二醇的中链脂肪酸酯和组合物及其使用方法 | |
CN1929829A (zh) | 作为d3激动剂的(s)-2-n-丙基氨基-5-羟基四氢化萘 | |
CN1457808A (zh) | 一种铁皮石斛复方制剂及制备和应用 | |
CN1850779A (zh) | β-榄香烯含氮衍生物及其制备方法和用途 | |
CN1649645A (zh) | 用于治疗肾癌的缩酚肽 | |
CN1301253C (zh) | 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途 | |
CN100342862C (zh) | 白藜芦醇低聚茋类化合物及其制法和其药物组合物与用途 | |
CN1908001A (zh) | 胆汁酸衍生物及其医药用途 | |
CN1186336C (zh) | 秦皮总香豆素的制备方法及其在制药中的应用 | |
CN1533277A (zh) | 用于预防或治疗由eNOS表达而引起的疾病的药物 | |
CN1486691A (zh) | 波棱素化合物及其制法和其药物组合物与用途 | |
CN1256094C (zh) | 3′-脱氧腺苷在制备降血脂药物中的应用 | |
CN1680390A (zh) | 卤代二氢青蒿素及其制备方法以及用途 | |
CN109280069A (zh) | 3β-羟基-麦角甾-5-烯甾类衍生物及其药物用途 | |
CN1523994A (zh) | 一种用于预防和/或治疗痴呆的以灵芝提取物、十八碳烯酰胺及其衍生物作为有效成分的组合物 | |
CN101007796A (zh) | 新型五元杂环化合物及其制备方法和医疗用途 | |
CN1199946C (zh) | 一种特异性吲哚类化合物及制备方法与其在治疗和预防癌症等疾病中的应用 | |
CN1295231C (zh) | 溴代二氢青蒿素 | |
CN1207392A (zh) | 维甲酰香豆素类化合物及其制备方法和含该化合物的药物组合物 | |
CN110003157A (zh) | 一种具有抗焦虑作用的新型黄酮类化合物及其应用 | |
CN1555805A (zh) | 注射用磷苯妥英钠冻干粉针剂及制备方法 | |
CN104262302A (zh) | L-抗坏血酸-6-(e-2-癸烯酸)酯或其衍生物以及它们的应用 | |
CN1732919A (zh) | 双环醇在制备预防和/或治疗急性酒精中毒和急慢性酒精性肝损伤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING MOLYKOTE TECHNOLOGY LTD. Free format text: FORMER OWNER: INST OF TOXIC MEDICINAL MATERIALS, P.L.A. ACADEMY OF MILITARY MEDICAL SCIENCES Effective date: 20070525 Owner name: SHENZHEN CITY DONGYANGGUANG INDUSTRY DEVELOPMENT Free format text: FORMER OWNER: BEIJING MOLYKOTE TECHNOLOGY LTD. Effective date: 20070525 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070525 Address after: 100088 Beijing City, Haidian District red No. 44 village of Zizhu Building Room 301 Patentee after: BEIJING MOLECULE SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: 100850 No. 27 Taiping Road, Beijing, Haidian District Patentee before: INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES PLA CHINA Effective date of registration: 20070525 Address after: 523871. E-25 building, Oriental Garden, Oct, Guangdong, Shenzhen Patentee after: Shenzhen East Sunshine Industrial Development Co.,Ltd. Address before: 100088 Beijing City, Haidian District red No. 44 village of Zizhu Building Room 301 Patentee before: BEIJING MOLECULE SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: DONGYANGGUANG PHARMACEUTICAL CO., LTD., GUANGDONG Free format text: FORMER OWNER: DONGYANGGUANG INDUSTRY DEVELOPMENT CO., LTD., SHENZHEN Effective date: 20120207 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 523871 SHENZHEN, GUANGDONG PROVINCE TO: 523000 DONGGUAN, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120207 Address after: No. 368 East Sun Technology Park on the village of Changan town in Guangdong province Dongguan City Zhen'an road 523000 Patentee after: SUNSHINE LAKE PHARMA Co.,Ltd. Address before: 523871. E-25 building, Oriental Garden, Oct, Guangdong, Shenzhen Patentee before: Shenzhen East Sunshine Industrial Development Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: RUYUAN HEC PHARM CO., LTD. Free format text: FORMER OWNER: GUANGDONG DONGYANGGUANG PHARMACEUTICAL CO., LTD. Effective date: 20150525 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 523000 DONGGUAN, GUANGDONG PROVINCE TO: 512721 SHAOGUAN, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150525 Address after: Dam zone 512721 Guangdong city of Shaoguan province Ruyuan Yao Autonomous County town of dragon bay Hou Gong Du milk Patentee after: RUYUAN HEC PHARM Co.,Ltd. Address before: No. 368 East Sun Technology Park on the village of Changan town in Guangdong province Dongguan City Zhen'an road 523000 Patentee before: SUNSHINE LAKE PHARMA Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070221 Termination date: 20210731 |
|
CF01 | Termination of patent right due to non-payment of annual fee |